Literature DB >> 8774144

Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

L Borrego1, B Maynard, E A Peterson, T George, L Iglesias, M S Peters, W Newman, G J Gleich, K M Leiferman.   

Abstract

Eosinophils, neutrophils, and mast cells have all been implicated in the pathogenesis of bullous pemphigoid (BP). To comparatively characterize the involvement of these cells in BP, 10 lesional skin biopsy specimens were identified retrospectively and studied for tissue localization of eosinophil, neutrophil, and mast cell granule proteins. Subsequently, multiple skin biopsies of lesions in various developmental stages were obtained from 3 patients with untreated BP. Involved and uninvolved skin specimens were also obtained from 2 patients. Using indirect immunofluorescence, retrospectively identified lesions showed eosinophils and extracellular granule protein deposition prominently in areas of blistering. Evolving lesions showed eosinophil granule protein deposition in all stages but was most marked in early erythematous and prebullous (urticarial) lesions and was minimal in uninvolved skin. Vascular cell adhesion molecule-1, E-selectin, and P-selectin were detected on vessels and very late activation antigen-4 was detected on mononuclear cells and eosinophils by immunoperoxidase staining of lesions. Eosinophil granule proteins were increased in the peripheral blood, urine, and blister fluid. Blister fluids caused increased eosinophil survival that was inhibited by antibodies to interleukin-5 and interleukin-3. Although neutrophil and mast cell infiltration was observed, extracellular granule protein deposition from these cells was minimal except in two specimens. These results demonstrate that eosinophils infiltrate and deposit granule proteins early in the development of BP lesions, that eosinophil-activating cytokines are present in blister fluid, and that eosinophil-selective adhesion molecules are present. These studies strongly support a role for eosinophils in blister formation in BP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774144      PMCID: PMC1861728     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.

Authors:  R E Jordon; J M Nordby; H Milstein
Journal:  J Lab Clin Med       Date:  1975-11

Review 2.  Cytokine generation by eosinophils.

Authors:  R Moqbel; F Levi-Schaffer; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

3.  Cellular events leading to blister formation in bullous pemphigoid.

Authors:  L Dubertret; B Bertaux; M Fosse; R Touraine
Journal:  Br J Dermatol       Date:  1980-12       Impact factor: 9.302

4.  Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone antibodies; in vitro studies.

Authors:  H Pehamberger; F Gschnait; K Konrad; K Holubar
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

5.  An immunofluorescent method for specific staining of eosinophil granule major basic protein.

Authors:  W V Filley; S J Ackerman; G J Gleich
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

6.  Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method.

Authors:  W R Gammon; C C Merritt; D M Lewis; W M Sams; C E Wheeler; J Carlo
Journal:  J Invest Dermatol       Date:  1981-06       Impact factor: 8.551

7.  Ultrastructural localization of in vivo-bound complement in bullous pemphigoid.

Authors:  B Schmidt-Ullrich; A Rule; G Schaumburg-Lever; C Leblanc
Journal:  J Invest Dermatol       Date:  1975-08       Impact factor: 8.551

8.  Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

Authors:  B U Wintroub; M C Mihm; E J Goetzl; N A Soter; K F Austen
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

9.  Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.

Authors:  T T Provost; T B Tomasi
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

10.  Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid.

Authors:  J R Carlo; W R Gammon; W M Sams; S Ruddy
Journal:  J Invest Dermatol       Date:  1979-12       Impact factor: 8.551

View more
  28 in total

Review 1.  Autoimmune subepidermal bullous skin diseases: the impact of recent findings for the dermatopathologist.

Authors:  Roberto Verdolini; Rino Cerio
Journal:  Virchows Arch       Date:  2003-06-11       Impact factor: 4.064

2.  Comparison of reactivity and epitope recognition between sera from American and Italian patients with oral pemphigoid.

Authors:  M Mignogna; A Lanza; L Rossiello; V Ruocco; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 3.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

4.  Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.

Authors:  Gail M Kephart; Jeffrey A Alexander; Amindra S Arora; Yvonne Romero; Thomas C Smyrk; Nicholas J Talley; Hirohito Kita
Journal:  Am J Gastroenterol       Date:  2009-11-03       Impact factor: 10.864

Review 5.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

6.  Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.

Authors:  C Günther; G Wozel; M Meurer; C Pfeiffer
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

7.  Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.

Authors:  Kelly N Messingham; Jeffrey W Wang; Heather M Holahan; Rupasree Srikantha; Samantha C Aust; Janet A Fairley
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960

8.  Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.

Authors:  A V Marzano; A Tedeschi; E Berti; D Fanoni; C Crosti; M Cugno
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

9.  Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid.

Authors:  R Chen; G Ning; M L Zhao; M G Fleming; L A Diaz; Z Werb; Z Liu
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Interleukin-16 expression and release in bullous pemphigoid.

Authors:  A Frezzolini; G Cianchini; M Ruffelli; S Cadoni; P Puddu; O De Pità
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.